CC
CDNA icon

Centiva Capital’s CareDx CDNA Stock Holding History

Centiva Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,584
Closed -$511K – 1304
2021
Q2 		$511K Buy
+5,584
New +$444K 0.01% 823

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Centiva Capital's CDNA Position: Q3 2021 in Review

Centiva Capital sold out of CareDx (CDNA) in Q3 2021, closing a stake of 5,584 shares — an estimated $511K sold.

Centiva Capital first reported a position in CDNA in Q2 2021 and held it in 1 quarter. The position peaked at $511K in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Centiva Capital reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Centiva Capital sold 5,584 CareDx shares in Q3 2021, an estimated $511K.
  • Centiva Capital first reported a position in CareDx in Q2 2021 and held it in 1 quarter.
  • Centiva Capital's CareDx position peaked at $511K in Q2 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.